Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia
Introduction: Prophylaxis is the treatment of choice for patients with severe hemophilia. Low adherence may limit the effectiveness of the prophylactic regimen, thereby compromising outcomes. Objective: The objective of this study was to validate the Brazilian version of the VERITAS-Pro prophylaxis...
Main Authors: | Adriana Aparecida Ferreira, Isabel Cristina Gonçalves Leite, Natalie August Duncan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S151684841730124X |
Similar Items
-
Measuring adherence in pediatric hemophilia patients: French-language adaptation of the VERITAS-Pro and VERITAS-PRN and psychometric properties
by: Sarah Bérubé, et al.
Published: (2019-01-01) -
Treatment adherence in hemophilia
by: Thornburg CD, et al.
Published: (2017-09-01) -
Cost analysis of hemophilia treatment in a Brazilian public blood center
by: Adriana Aparecida Ferreira, et al.
Published: (2020-12-01) -
Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B
by: Djambas Khayat C
Published: (2016-11-01) -
Patient and parent preferences for characteristics of prophylactic treatment in hemophilia
by: Furlan R, et al.
Published: (2015-11-01)